✨ Unlock Unlimited Data Exports & Disclosures Access with Tracenable Pro. Learn More →

Novozymes A/S

Common Name
Novozymes
Country
Denmark
Sector
Basic Materials
Industry
Specialty Chemicals
Employees
10,582
Ticker
NSIS B
Exchange
NASDAQ COPENHAGEN A/S
Description
Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, Latin America, and in...

Novozymes's Financial Statements Preview

Below are the financial statements of Novozymes, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of EUR
2024 2024-01-01 - 2024-12-31
2023 2023-01-01 - 2023-12-31
Net sales
3,833.5a
2,402.2a
Cost of goods sold
-2,024a
-1,097.4a
Gross profit
1,809.5a
1,304.8a
Sales and distribution costs
-550.9a
-317.4a
Research and development costs
-413.2a
-270.7a
Administrative costs
-214.6a
-128.7a
Other operating income
28.2a
22.9a
Operating profit (EBIT) before special items
659a
610.9a
Special items
-158a
-77.3a
Operating profit (EBIT)
501a
533.6a
Share of result in associates
-3.5a
-2.4a
Financial income
26.9a
37.8a
Financial costs
-107.3a
-44.3a
Profit before tax
417.1a
524.7a
Tax
-111.3a
-116.8a
Net profit
305.8a
407.9a
Attributable to shareholders of Novozymes A/S
305.8a
405.9a
Non-controlling interests
0a
2a
Limited Data Preview
You are viewing a limited preview of Novozymes’s income statement data. The reported financial values are complete. The full dataset, available for download, additionally includes structured metadata for each line item, such as line item role (line item, subtotal, total) and financial classification (e.g., assets, liabilities, equity, revenue, expenses).
Unrestricted Access to Data and Sources
pro
Remove manual data sourcing from your workflow. Upgrade to Tracenable Pro for unrestricted access to datasets and disclosures across 8,500+ companies with over 10 years of historical coverage.
Download complete datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace values back to original sources
Formats Included
Excel
CSV
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Novozymes’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Novozymes’s data sources below and access millions more through our Disclosure Search.

a. Novozymes's Annual Report 2024
a. Novozymes's Annual Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?